A warning that advertising Ozempic (semaglutide) is prohibited
The TGA warns social media influencers and advertisers not to advertise this prescription medicine.
Published
Related content
-
Myers Pharmacy fined for alleged unlawful advertising of Ozempic
An infringement notice of $18,780 has been issued to Myers Pharmacy Pty Ltd for the alleged unlawful advertising of Ozempic, a prescription-only medicine. -
$10 million penalty ordered against Peptide Clinics Pty Ltd for advertising breaches
The Federal Court has imposed substantial penalties on Peptide Clinics Australia -
TGA warns advertising prescription-only weight-loss medicine is prohibited
The TGA reminds businesses and media outlets that it is unlawful to publicly advertise prescription-only medicines, including prescription-only weight loss medicines.